You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Oseltamivir and early deterioration leading to death: a proportional mortality study for 2009A/H1N1 influenza.
|
|---|---|
| Published in |
Pharmaceuticals Policy & Law, January 2011
|
| DOI | 10.3233/jrs-2011-0545 |
| Pubmed ID | |
| Authors |
Rokuro Hama, Mark Jones, Hiroki Okushima, Masahiro Kitao, Narumi Noda, Keiji Hayashi, Keiko Sakaguchi |
| Abstract |
To examine the epidemiological association between sudden deterioration leading to death and Tamiflu use. |
X Demographics
The data shown below were collected from the profiles of 382 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 100 | 26% |
| Turkey | 12 | 3% |
| United Kingdom | 7 | 2% |
| Australia | 6 | 2% |
| Canada | 4 | 1% |
| France | 3 | <1% |
| South Africa | 3 | <1% |
| Ireland | 2 | <1% |
| Germany | 2 | <1% |
| Other | 12 | 3% |
| Unknown | 231 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 342 | 90% |
| Practitioners (doctors, other healthcare professionals) | 28 | 7% |
| Scientists | 6 | 2% |
| Science communicators (journalists, bloggers, editors) | 5 | 1% |
| Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 5% |
| Unknown | 20 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 5 | 24% |
| Student > Bachelor | 3 | 14% |
| Student > Master | 3 | 14% |
| Student > Ph. D. Student | 2 | 10% |
| Other | 2 | 10% |
| Other | 3 | 14% |
| Unknown | 3 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 38% |
| Agricultural and Biological Sciences | 2 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 10% |
| Economics, Econometrics and Finance | 2 | 10% |
| Nursing and Health Professions | 1 | 5% |
| Other | 3 | 14% |
| Unknown | 3 | 14% |
Attention Score in Context
This research output has an Altmetric Attention Score of 303. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2024.
All research outputs
#116,471
of 25,782,229 outputs
Outputs from Pharmaceuticals Policy & Law
#3
of 202 outputs
Outputs of similar age
#427
of 192,622 outputs
Outputs of similar age from Pharmaceuticals Policy & Law
#1
of 15 outputs
Altmetric has tracked 25,782,229 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 202 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,622 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.